A case of treatment-resistant bipolar depression and comorbid OCD treated with deep brain stimulation of the medial forebrain bundle: 5 years follow-up results

[1]  T. Schlaepfer,et al.  Discontinuation of Superolateral Medial Forebrain Bundle Deep Brain Stimulation for Treatment-Resistant Depression Leads to Critical Relapse , 2019, Biological Psychiatry.

[2]  H. Urbach,et al.  Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial , 2019, Neuropsychopharmacology.

[3]  D. Denys,et al.  Individual white matter bundle trajectories are associated with deep brain stimulation response in obsessive-compulsive disorder , 2019, Brain Stimulation.

[4]  J. Soares,et al.  A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression , 2018, Translational Psychiatry.

[5]  A. Carvalho,et al.  Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications , 2018, Molecular Psychiatry.

[6]  T. Schlaepfer,et al.  Deep brain stimulation to the medial forebrain bundle for depression- long-term outcomes and a novel data analysis strategy , 2017, Brain Stimulation.

[7]  H. Urbach,et al.  The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder , 2016, CNS Spectrums.

[8]  B. Mädler,et al.  Rapid Effects of Deep Brain Stimulation for Treatment-Resistant Major Depression , 2013, Biological Psychiatry.

[9]  Mark S. George,et al.  WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[10]  P. Girardi,et al.  Treatment‐resistant bipolar depression: towards a new definition , 2009, Acta psychiatrica Scandinavica.

[11]  A. Altamura,et al.  Deep Brain Stimulation of the Medial Forebrain Bundle in a Patient with Treatment-Resistant Bipolar Depression and Comorbid OCD: Acute and 12-Month Follow-Up Results , 2017 .